Related Experiment Videos
Two possibly related cases of Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal
F Soriano1, J L Rodriguez-Tudela, J L Gómez-Garcés
1Department of Clinical Microbiology, Fundación Jimenez Dîaz, Madrid, Spain.
Abstract:
This paper describes two possibly related cases of hospital-acquired Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD). To our knowledge these are the first reported cases of CAPD peritonitis with possible cross-contamination by such a microorganism. Investigations for mycobacteria should be performed in all cases of culture-negative peritonitis, especially those which do not respond to the usual antimicrobial therapy.
Insights
Two cases of hospital-acquired Mycobacterium fortuitum peritonitis linked to continuous ambulatory peritoneal dialysis (CAPD) were reported. Early mycobacterial investigation is crucial for culture-negative peritonitis unresponsive to standard treatments.
Area of Science:
- Infectious Diseases
- Nephrology
- Microbiology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for kidney failure.
- Hospital-acquired infections pose a risk to CAPD patients.
Observation:
- Two patients undergoing CAPD developed peritonitis.
- The peritonitis was caused by Mycobacterium fortuitum, a rapidly growing mycobacterium.
- Possible cross-contamination within the hospital setting was suspected.
Findings:
- These are the first reported cases of CAPD peritonitis caused by Mycobacterium fortuitum.
- The microorganism may be acquired in a hospital setting.
Implications:
- Healthcare providers should consider mycobacterial infections in CAPD peritonitis cases.
- Investigating for mycobacteria is essential for culture-negative peritonitis unresponsive to conventional antibiotics.
- This highlights the importance of infection control in CAPD units.